In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic <i>E. coli</i>

<b>Background:</b> Urinary tract infections (UTIs) caused by the multidrug resistance (MDR) phenotype termed extended-spectrum beta lactamase (ESBL)-producing <i>E. coli</i> is a significant and growing global health concern. In response to the rising prevalence, the novel Beta Lactam-Beta Lactamase...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Ali Atoom, Bayan Alzubi, Dana Barakat, Rana Abu-Gheyab, Dalia Ismail-Agha, Awatef Al-Kaabneh, Nawfal Numan
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2025-06-01
Schriftenreihe:	Antibiotics
Schlagworte:	beta-lactam antibiotics beta-lactamase inhibitors extended-spectrum beta-lactamase cefaclor <i>Escherichia coli</i> clavulanic acid
Online-Zugang:	https://www.mdpi.com/2079-6382/14/6/603
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!